CN1158302C - 具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 - Google Patents
具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 Download PDFInfo
- Publication number
- CN1158302C CN1158302C CNB021135916A CN02113591A CN1158302C CN 1158302 C CN1158302 C CN 1158302C CN B021135916 A CNB021135916 A CN B021135916A CN 02113591 A CN02113591 A CN 02113591A CN 1158302 C CN1158302 C CN 1158302C
- Authority
- CN
- China
- Prior art keywords
- arginine
- aescine
- hours
- detumescence
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 10
- 206010061218 Inflammation Diseases 0.000 title abstract description 4
- 230000017531 blood circulation Effects 0.000 title abstract description 4
- 230000004054 inflammatory process Effects 0.000 title abstract description 4
- 230000008569 process Effects 0.000 title description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000004475 Arginine Substances 0.000 claims abstract description 43
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 235000009697 arginine Nutrition 0.000 claims description 41
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 13
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 10
- 229930064664 L-arginine Natural products 0.000 claims description 10
- 235000014852 L-arginine Nutrition 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims description 2
- 229930028154 D-arginine Natural products 0.000 claims description 2
- 230000008961 swelling Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 229940011399 escin Drugs 0.000 abstract 3
- 229930186222 escin Natural products 0.000 abstract 3
- 206010047163 Vasospasm Diseases 0.000 abstract 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 241000700159 Rattus Species 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 239000007924 injection Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 239000008354 sodium chloride injection Substances 0.000 description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 238000011179 visual inspection Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 240000001307 Myosotis scorpioides Species 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000000078 claw Anatomy 0.000 description 3
- 235000010181 horse chestnut Nutrition 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 241000157282 Aesculus Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000157280 Aesculus hippocastanum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical compound CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021135916A CN1158302C (zh) | 2002-04-10 | 2002-04-10 | 具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021135916A CN1158302C (zh) | 2002-04-10 | 2002-04-10 | 具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1376675A CN1376675A (zh) | 2002-10-30 |
CN1158302C true CN1158302C (zh) | 2004-07-21 |
Family
ID=4742702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021135916A Expired - Lifetime CN1158302C (zh) | 2002-04-10 | 2002-04-10 | 具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1158302C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100428940C (zh) * | 2005-07-15 | 2008-10-29 | 武汉爱民制药有限公司 | 七叶皂苷的药物组合物及其制备方法和其制药用途 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100357312C (zh) * | 2005-07-15 | 2007-12-26 | 武汉爱民制药有限公司 | 赖氨酸七叶皂苷及其制备方法和其用途 |
CN102805750B (zh) * | 2011-05-31 | 2015-09-23 | 天津药物研究院 | 一种七叶皂苷衍生物及其盐的组合物、其制备方法和医药用途 |
CN104288167B (zh) * | 2014-10-29 | 2017-08-25 | 马应龙药业集团股份有限公司 | 一种治疗痔疮的七叶皂苷钠制剂及其制备方法 |
-
2002
- 2002-04-10 CN CNB021135916A patent/CN1158302C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100428940C (zh) * | 2005-07-15 | 2008-10-29 | 武汉爱民制药有限公司 | 七叶皂苷的药物组合物及其制备方法和其制药用途 |
Also Published As
Publication number | Publication date |
---|---|
CN1376675A (zh) | 2002-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062343A (zh) | 一种用于治疗皮肤瘤、癣、疣、疱疹的外用中药 | |
CN102274174B (zh) | 苯并咪唑类药物油混悬剂 | |
EA029649B1 (ru) | Гель на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии и способ его приготовления | |
CN1158302C (zh) | 具有消肿抗炎改善血液循环的精氨酸七叶皂苷及制备方法 | |
CN1293101C (zh) | 银耳多糖,其制备方法和以该化合物为活性成分的药物组合物 | |
CN1939893A (zh) | 赖氨酸酮洛芬及其制备方法 | |
CN108785374A (zh) | 清香桂皮肤抑菌凝胶及其制备方法 | |
CN1806850A (zh) | 一种透皮给药增强剂的组合物及其在外用药中的应用 | |
CN1398861A (zh) | 秦皮总香豆素的制备方法及其在制药中的应用 | |
CN1943554A (zh) | 一种阿维菌素透皮剂及制备方法 | |
CN1723956A (zh) | 一种治疗慢性胃炎、胃癌的药物及其制备方法 | |
CN1939328A (zh) | 葛根素注射用制剂 | |
CN1679861A (zh) | 一种治疗牙痛的药物 | |
CN110664807A (zh) | 一种具有协同抗黑色素瘤功效的药物组合物及其应用 | |
CN1376670A (zh) | 具有镇痛抗炎的精氨酸酮洛芬及制备方法 | |
RU2813546C1 (ru) | Средство для лечения и профилактики послеродовых заболеваний у коров | |
CN1167421C (zh) | 含吡咯并喹啉醌的治疗铅中毒的药物组合物 | |
CN1262099A (zh) | 阿苯达唑乳剂 | |
CN1194696C (zh) | 一种注射用药物组合物、含有该药物组合物的制剂及其制备方法 | |
CN102266387B (zh) | 一种治疗口蹄疫的药剂及生产治疗口蹄疫的药剂的方法 | |
CN100421672C (zh) | 抗肿瘤的复方香菇多糖制剂及其制备方法 | |
CN1579417A (zh) | 一种复方脱水利尿药物组合物及其制备方法 | |
CN1056748C (zh) | 土贝母苷甲制备治疗白血病的药物用途 | |
CN1772120A (zh) | 一种中药组合物 | |
CN1813836A (zh) | 一种治疗心脑血管的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG GREEN LEAF PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENGNUO SCIENCE AND TECHNOLOGY DEVELOPMENT CO LTD, CHENGDU Effective date: 20050204 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20050204 Address after: 264003, No. 9, Po Yuen Road, Laishan District, Shandong, Yantai Patentee after: Luye Pharmaceutical Co., Ltd., Shandong Address before: 610041 No. 111, Xiaojiahe street, hi tech Zone, Sichuan, Chengdu Patentee before: Shengnuo Science and Technology Development Co., Ltd., Chengdu |
|
C56 | Change in the name or address of the patentee |
Owner name: SHANDONG LUYE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME OR ADDRESS: SHANDONG GREEN LEAF PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 264003, No. 9, Po Yuen Road, Laishan District, Shandong, Yantai Patentee after: Shandong Luye Pharma Co., Ltd. Address before: 264003, No. 9, Po Yuen Road, Laishan District, Shandong, Yantai Patentee before: Luye Pharmaceutical Co., Ltd., Shandong |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20040721 |